SOPHiA GENETICS S.A. ( SOPH) - Key Metrics
SOPH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.32 | -$0.30 | -$0.10 | -$0.14 |
| 2026Q1 | $0.30 | -$0.27 | -$0.23 | -$0.24 |
| 2025Q4 | $0.32 | -$0.28 | -$0.13 | -$0.14 |
| 2025Q3 | $0.29 | -$0.30 | -$0.13 | -$0.13 |
| 2025Q2 | $0.27 | -$0.33 | -$0.12 | -$0.15 |
SOPH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.81 |
| 2026Q1 | 0% | -4.58 |
| 2025Q4 | 0% | -4.17 |
| 2025Q3 | 0% | -3.97 |
| 2025Q2 | 0% | -2.35 |
SOPH
Price: $7.87
52 week price:
Earnings Per Share: -1.16 USD
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Country: Switzerland
Volume: 4190
Market Capitalization: 696.3 million